<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35545379</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2044-6055</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMJ open</Title>
          <ISOAbbreviation>BMJ Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.</ArticleTitle>
        <Pagination>
          <StartPage>e052833</StartPage>
          <MedlinePgn>e052833</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e052833</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2021-052833</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Ophthalmic conditions including anterior uveitis (AU), episcleritis and scleritis may occur in association with the inflammatory bowel diseases (IBD) as ophthalmic extraintestinal manifestations. The aim of this study was to assess the risk of a later IBD diagnosis in those presenting with IBD associated ocular inflammation (IAOI).</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText>
          <AbstractText Label="SETTING" NlmCategory="METHODS">Primary care UK database.</AbstractText>
          <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">38 805 subjects with an IAOI were identified (median age 51 (38-65), 57% women) and matched to 153 018 subjects without IAOI.</AbstractText>
          <AbstractText Label="MEASURES" NlmCategory="METHODS">The risk of a subsequent diagnosis of IBD in subjects with IAOIs compared with age/sex matched subjects without IAOI. HRs were adjusted for age, sex, body mass index, deprivation, comorbidity, smoking, baseline axial arthropathy, diarrhoea, loperamide prescription, anaemia, lower gastrointestinal bleeding and abdominal pain.Logistic regression was used to produce a prediction model for a diagnosis of IBD within 3 years of an AU diagnosis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">213 (0.6%) subsequent IBD diagnoses (102 ulcerative colitis (UC) and 111 Crohn's disease (CD)) were recorded in those with IAOIs and 329 (0.2%) (215 UC and 114 CD) in those without. Median time to IBD diagnosis was 882 (IQR 365-2043) days in those with IAOI and 1403 (IQR 623-2516) in those without. The adjusted HR for a subsequent diagnosis of IBD was 2.25 (95% CI 1.89 to 2.68), p&lt;0.001; for UC 1.65 (95% CI 1.30 to 2.09), p&lt;0.001; and for CD 3.37 (95% CI 2.59 to 4.40), p&lt;0.001 in subjects with IAOI compared with those without.Within 3 years of an AU diagnosis, 84 (0.5%) subjects had a recorded diagnosis of IBD. The prediction model performed well with a C-statistic of 0.75 (95% CI 0.69 to 0.80).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Subjects with IAOI have a twofold increased risk of a subsequent IBD diagnosis. Healthcare professionals should be alert for potential signs and symptoms of IBD in those presenting with ophthalmic conditions associated with IBD.</AbstractText>
          <CopyrightInformation>© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>King</LastName>
            <ForeName>Dominic</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0003-1153-7826</Identifier>
            <AffiliationInfo>
              <Affiliation>Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chandan</LastName>
            <ForeName>Joht Singh</ForeName>
            <Initials>JS</Initials>
            <Identifier Source="ORCID">0000-0002-9561-5141</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Tom</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Gastroenterology Unit and Kennedy Institute of Rheumatology, Oxford University, Oxford, Oxfordshire, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Denniston</LastName>
            <ForeName>Alastair K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, University Hospitals Birmingham NHSFT, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braithwaite</LastName>
            <ForeName>Tasanee</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Medical Eye Unit, Guy's and St Thomas' Hospitals NHS Trust, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Niranthrankumar</LastName>
            <ForeName>Krishnarajah</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reulen</LastName>
            <ForeName>Raoul</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adderley</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-0543-3254</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK n.j.adderley@bham.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trudgill</LastName>
            <ForeName>Nigel J</ForeName>
            <Initials>NJ</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMJ Open</MedlineTA>
        <NlmUniqueID>101552874</NlmUniqueID>
        <ISSNLinking>2044-6055</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003424" MajorTopicYN="Y">Crohn Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">gastroenterology</Keyword>
        <Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword>
        <Keyword MajorTopicYN="N">ophthalmology</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: KN reports grant from AstraZeneca, Sanofi and Boehringer Ingelheim, outside the submitted work. NJT reports grants from Dr Falk, MSD, AstraZeneca and Pfizer, outside the submitted work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>21</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35545379</ArticleId>
        <ArticleId IdType="pmc">PMC9096531</ArticleId>
        <ArticleId IdType="doi">10.1136/bmjopen-2021-052833</ArticleId>
        <ArticleId IdType="pii">bmjopen-2021-052833</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Halling ML, Kjeldsen J, Knudsen T, et al. . Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol
2017;23:6137–46. 10.3748/wjg.v23.i33.6137</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v23.i33.6137</ArticleId>
            <ArticleId IdType="pmc">PMC5597505</ArticleId>
            <ArticleId IdType="pubmed">28970729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eaton WW, Rose NR, Kalaydjian A, et al. . Epidemiology of autoimmune diseases in Denmark. J Autoimmun
2007;29:1–9. 10.1016/j.jaut.2007.05.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2007.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC2717015</ArticleId>
            <ArticleId IdType="pubmed">17582741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greuter T, Navarini A, Vavricka SR. Skin manifestations of inflammatory bowel disease. Clin Rev Allergy Immunol
2017;53:413–27. 10.1007/s12016-017-8617-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12016-017-8617-4</ArticleId>
            <ArticleId IdType="pubmed">28643285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danese S, Semeraro S, Papa A, et al. . Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol
2005;11:7227–36. 10.3748/wjg.v11.i46.7227</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v11.i46.7227</ArticleId>
            <ArticleId IdType="pmc">PMC4725142</ArticleId>
            <ArticleId IdType="pubmed">16437620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang BR, Choi N-K, Kim M-S, et al. . Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLoS One
2018;13:e0200363. 10.1371/journal.pone.0200363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0200363</ArticleId>
            <ArticleId IdType="pmc">PMC6039042</ArticleId>
            <ArticleId IdType="pubmed">29990326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol
2011;7:235–41.</Citation>
        </Reference>
        <Reference>
          <Citation>Monnet D, Breban M, Hudry C, et al. . Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology
2004;111:802–9. 10.1016/j.ophtha.2003.07.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2003.07.011</ArticleId>
            <ArticleId IdType="pubmed">15051216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin TM, Rosenbaum JT. An update on the genetics of HLA B27-associated acute anterior uveitis. Ocul Immunol Inflamm
2011;19:108–14. 10.3109/09273948.2011.559302</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09273948.2011.559302</ArticleId>
            <ArticleId IdType="pmc">PMC3083239</ArticleId>
            <ArticleId IdType="pubmed">21428748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopkins DJ, Horan E, Burton IL, et al. . Ocular disorders in a series of 332 patients with Crohn's disease. Br J Ophthalmol
1974;58:732–7. 10.1136/bjo.58.8.732</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.58.8.732</ArticleId>
            <ArticleId IdType="pmc">PMC1215010</ArticleId>
            <ArticleId IdType="pubmed">4433484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crohn B. Ocular lesions complicating ulcerative colitis. Am J Med Sci
1925;169:260–7.</Citation>
        </Reference>
        <Reference>
          <Citation>Mintz R, Feller ER, Bahr RL, et al. . Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis
2004;10:135–9. 10.1097/00054725-200403000-00012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00054725-200403000-00012</ArticleId>
            <ArticleId IdType="pubmed">15168814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Troncoso LL, Biancardi AL, de Moraes HV, et al. . Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol
2017;23:5836–48. 10.3748/wjg.v23.i32.5836</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v23.i32.5836</ArticleId>
            <ArticleId IdType="pmc">PMC5583569</ArticleId>
            <ArticleId IdType="pubmed">28932076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chams S, Badran R, Sayegh SE, et al. . Inflammatory bowel disease: looking beyond the tract. Int J Immunopathol Pharmacol
2019;33:205873841986656. 10.1177/2058738419866567</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2058738419866567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harbord M, Annese V, Vavricka SR, et al. . The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis
2016;10:239–54. 10.1093/ecco-jcc/jjv213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ecco-jcc/jjv213</ArticleId>
            <ArticleId IdType="pmc">PMC4957476</ArticleId>
            <ArticleId IdType="pubmed">26614685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol
2019;13:307–17. 10.1080/17474124.2019.1574569</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17474124.2019.1574569</ArticleId>
            <ArticleId IdType="pubmed">30791773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal
2015;2015:1–5. 10.1155/2015/438402</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2015/438402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vavricka SR, Rogler G, Gantenbein C, et al. . Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis
2015;21:1794–800. 10.1097/MIB.0000000000000429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MIB.0000000000000429</ArticleId>
            <ArticleId IdType="pubmed">26020601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vavricka SR, Schoepfer A, Scharl M, et al. . Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis
2015;21:1982–92. 10.1097/MIB.0000000000000392</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MIB.0000000000000392</ArticleId>
            <ArticleId IdType="pmc">PMC4511685</ArticleId>
            <ArticleId IdType="pubmed">26154136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blak BT, Thompson M, Dattani H, et al. . Generalisability of the health improvement network (thin) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care
2011;19:251–5. 10.14236/jhi.v19i4.820</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14236/jhi.v19i4.820</ArticleId>
            <ArticleId IdType="pubmed">22828580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nhs NB. What are the read codes?
Health Libr Rev
1994;11:177–82. 10.1046/j.1365-2532.1994.1130177.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2532.1994.1130177.x</ArticleId>
            <ArticleId IdType="pubmed">10139676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf
2009;18:76–83. 10.1002/pds.1688</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pds.1688</ArticleId>
            <ArticleId IdType="pubmed">19065600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Booth N. What are the read codes?
Health Libr Rev
1994;11:177–82. 10.1046/j.1365-2532.1994.1130177.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2532.1994.1130177.x</ArticleId>
            <ArticleId IdType="pubmed">10139676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lévesque LE, Hanley JA, Kezouh A, et al. . Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ
2010;340:b5087. 10.1136/bmj.b5087</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.b5087</ArticleId>
            <ArticleId IdType="pubmed">20228141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis JD, Brensinger C, Bilker WB, et al. . Validity and completeness of the general practice research database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf
2002;11:211–8. 10.1002/pds.698</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pds.698</ArticleId>
            <ArticleId IdType="pubmed">12051120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis JD, Schinnar R, Bilker WB, et al. . Validation studies of the health improvement network (thin) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf
2007;16:393–401. 10.1002/pds.1335</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pds.1335</ArticleId>
            <ArticleId IdType="pubmed">17066486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Card TR, Langan SM, Chu TPC. Extra-Gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported. Dig Dis Sci
2016;61:2619–26. 10.1007/s10620-016-4195-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-016-4195-1</ArticleId>
            <ArticleId IdType="pubmed">27193564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langan SM, Groves RW, Card TR, et al. . Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol
2012;132:2166–70. 10.1038/jid.2012.130</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jid.2012.130</ArticleId>
            <ArticleId IdType="pubmed">22534879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charlton R, Green A, Shaddick G, et al. . Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study. Ann Rheum Dis
2018;77:277–80. 10.1136/annrheumdis-2017-212328</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2017-212328</ArticleId>
            <ArticleId IdType="pubmed">29092855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marston L, Carpenter JR, Walters KR, et al. . Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study. BMJ Open
2014;4:e004958. 10.1136/bmjopen-2014-004958</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2014-004958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>StataCorp . Stata statistical software: release 16, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Baatz H, Scharioth GB, de Ortueta D, et al. . Age distribution of patients presenting with uveitis. Open Ophthalmol J
2007;1:23–4. 10.2174/1874364100701010023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1874364100701010023</ArticleId>
            <ArticleId IdType="pmc">PMC2605695</ArticleId>
            <ArticleId IdType="pubmed">19478860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu TT, Reynolds MM, Hodge DO, et al. . Epidemiology and clinical characteristics of Episcleritis and scleritis in Olmsted County, Minnesota. Am J Ophthalmol
2020;217:317–24. 10.1016/j.ajo.2020.04.043</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2020.04.043</ArticleId>
            <ArticleId IdType="pmc">PMC7492378</ArticleId>
            <ArticleId IdType="pubmed">32437669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmon JF, Wright JP, Murray AD. Ocular inflammation in Crohn's disease. Ophthalmology
1991;98:480–4. 10.1016/S0161-6420(91)32268-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(91)32268-1</ArticleId>
            <ArticleId IdType="pubmed">2052301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orchard TR, Chua CN, Ahmad T, et al. . Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology
2002;123:714–8. 10.1053/gast.2002.35396</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/gast.2002.35396</ArticleId>
            <ArticleId IdType="pubmed">12198697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology
1994;107:103–8. 10.1016/0016-5085(94)90066-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0016-5085(94)90066-3</ArticleId>
            <ArticleId IdType="pubmed">8020652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci
1999;44:1–13. 10.1023/A:1026629528233</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1026629528233</ArticleId>
            <ArticleId IdType="pubmed">9952216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pathanapitoon K, Dodds EM, Cunningham ET, et al. . Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm
2017;25:569–76. 10.1080/09273948.2016.1185527</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2016.1185527</ArticleId>
            <ArticleId IdType="pubmed">27428361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vavricka SR, Brun L, Ballabeni P, et al. . Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol
2011;106:110–9. 10.1038/ajg.2010.343</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2010.343</ArticleId>
            <ArticleId IdType="pubmed">20808297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol
2006;12:4819–31. 10.3748/wjg.v12.i30.4819</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v12.i30.4819</ArticleId>
            <ArticleId IdType="pmc">PMC4087615</ArticleId>
            <ArticleId IdType="pubmed">16937463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill QA, Stamps R, Massey E, et al. . Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol
2017;177:208–20. 10.1111/bjh.14654</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.14654</ArticleId>
            <ArticleId IdType="pubmed">28369704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev
2002;16:87–96. 10.1054/blre.2002.0193</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1054/blre.2002.0193</ArticleId>
            <ArticleId IdType="pubmed">12127952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ottaviano G, Salvatore S, Salvatoni A, et al. . Ocular manifestations of paediatric inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis
2018;12:870–9. 10.1093/ecco-jcc/jjy029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ecco-jcc/jjy029</ArticleId>
            <ArticleId IdType="pubmed">29518184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King D, Reulen RC, Thomas T, et al. . Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018. Aliment Pharmacol Ther
2020;51:922–34. 10.1111/apt.15701</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.15701</ArticleId>
            <ArticleId IdType="pubmed">32237083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones G-R, Lyons M, Plevris N, et al. . Ibd prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut
2019;68:1953–60. 10.1136/gutjnl-2019-318936</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2019-318936</ArticleId>
            <ArticleId IdType="pmc">PMC6839733</ArticleId>
            <ArticleId IdType="pubmed">31300515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng SC, Shi HY, Hamidi N, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet
2017;390:2769–78. 10.1016/S0140-6736(17)32448-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(17)32448-0</ArticleId>
            <ArticleId IdType="pubmed">29050646</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
